Research
Molecular
Tirzepatide improves β-cell function in T2D patients by reprogramming stressed β cells and restoring β-cell identity through FOXO1-dependent transcriptional reactivation.
Practitioners may consider tirzepatide as a therapeutic option for improving β-cell function in T2D patients.
StrongSupportsmedium confidence
Hence, our study suggested that tirzepatide restores β-cell function in T2D by reprogramming stressed β cells and re-establishing β-cell identity through FOXO1-dependent transcriptional reactivation.
Why this rating
The study involves both animal and human data, indicating strong evidence.
Source
Tirzepatide improves pancreatic β-cell function in mice and patients with type 2 diabetes
Zhehui Li et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2026
other
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →